Collectively, our data supports recent findings connecting G9a expression to cell proliferation and canonical Wnt activity in CRC [18, 20, 22], as well as previous demonstration that G9a expression enhances in vivo tumorigenicity and resistance to ionizing radiation in HT29 cells [37]. This evidence concerns the gene EHMT2 and colorectal carcinoma.